Cytokinetics Inc (CYTK.OQ)
7.20USD
23 Apr 2018
-- (--)
$7.20
--
--
--
--
121,426
$17.20
$6.80
Fri, Feb 16 2018
BRIEF-Cytokinetics Qtrly Net Loss Per Share $0.75
* CYTOKINETICS, INC. REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS
BRIEF-Cytokinetics Announces Progress Against Vision 2020
* CYTOKINETICS INC - RESULTS FROM FOUR CLINICAL TRIALS OF CK-2127107 EXPECTED IN 2018
Cytokinetics sinks on abandoning ALS drug after failed trial
Cytokinetics Inc shares plummeted nearly 28 percent on Tuesday after the drugmaker said it would stop developing one of its treatments for ALS, a fatal neuro-degenerative disorder, after the drug failed to improve lung function in a key trial.
BRIEF-Cytokinetics Inc announces negative results from VITALITY-ALS
* Phase 3 clinical trial of Tirasemtiv in patients with ALS did not meet primary or secondary endpoints
Cytokinetics' neuro-degenerative drug fails late-stage trial
Nov 21 Cytokinetics Inc said on Tuesday its drug to treat a type of neuro-degenerative disorder failed to meet the main goal of a late-stage trial.
BRIEF-Cytokinetics files for potential mixed shelf, size undisclosed
* Cytokinetics Inc files for potential mixed shelf, size undisclosed - SEC Filing Source text: http://bit.ly/2hauCBo Further company coverage:
BRIEF-Cytokinetics enters into second amendment to certain loan and security agreement
* Cytokinetics - on Oct 27, entered into second amendment to certain loan and security agreement dated as of October 19, 2015
BRIEF-Cytokinetics reports Q3 loss of $0.60/shr
* Cytokinetics, Inc. reports third quarter 2017 financial results
- Cytokinetics' (CYTK) CEO Robert Blum on Q4 2017 Results - Earnings Call Transcript
- Cytokinetics: Multiple Catalysts Could Help With Rebound
- 3 Things In Biotech You Should Learn Today: November 22, 2017
- Your Daily Pharma Scoop: Progenics Looks Promising, Big Week For Dynavax, Keryx Ahead Of Catalyst
- Cytokinetics (CYTK) CEO Robert Blum on Q3 2017 Results - Earnings Call Transcript
- Cytokinetics, Incorporated 2017 Q3 - Results - Earnings Call Slides